• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板衍生生长因子受体-β基因表达在II/III期胃癌S-1辅助化疗中的临床意义

Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy.

作者信息

Higuchi Akio, Oshima Takashi, Yoshihara Kazue, Sakamaki Kentaro, Aoyama Toru, Suganuma Nobuyasu, Yamamoto Naoto, Sato Tsutomu, Cho Haruhiko, Shiozawa Manabu, Yoshikawa Takaki, Rino Yasushi, Kunisaki Chikara, Imada Toshio, Masuda Munetaka

机构信息

Department of Surgery, Yokohama City University, Yokohama, Kanagawa 236-0004, Japan.

Clinical Research Coordinating Center, Yokohama City University Medical Center, Yokohama, Kanagawa 232-0024, Japan.

出版信息

Oncol Lett. 2017 Feb;13(2):905-911. doi: 10.3892/ol.2016.5494. Epub 2016 Dec 14.

DOI:10.3892/ol.2016.5494
PMID:28356977
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5351282/
Abstract

Overall survival remains unsatisfactory in stage II/III gastric cancer, even after curative surgery and adjuvant chemotherapy. Platelet-derived growth factor receptor-β (-β) is associated with the proliferation of cancer cells. The present study therefore investigated the association of -β gene expression with patient outcome in 134 stage II/III gastric cancer patients who received adjuvant chemotherapy with S-1. Relative -β gene expression was measured in surgical cancer tissue and adjacent normal mucosa specimens by reverse transcription-quantitative polymerase chain reaction. The -β gene expression levels were found to be significantly higher in the cancer tissues compared with the adjacent normal mucosa. A high level of -β gene expression was associated with a significantly poorer 5-year overall survival rate compared with a low level of -β expression. Upon multivariate analysis, -β gene expression was found to be an independent predictor of survival. Overall, the study indicates that -β overexpression in gastric cancer tissues is a useful independent predictor of outcome in patients with stage II/III gastric cancer who receive adjuvant chemotherapy with S-1.

摘要

即使经过根治性手术和辅助化疗,II/III期胃癌患者的总生存期仍不尽人意。血小板衍生生长因子受体-β(PDGFR-β)与癌细胞增殖有关。因此,本研究调查了134例接受S-1辅助化疗的II/III期胃癌患者中PDGFR-β基因表达与患者预后的关系。通过逆转录定量聚合酶链反应测量手术切除的癌组织和相邻正常黏膜标本中的相对PDGFR-β基因表达。结果发现,与相邻正常黏膜相比,癌组织中的PDGFR-β基因表达水平显著更高。与低水平的PDGFR-β表达相比,高水平的PDGFR-β基因表达与显著更差的5年总生存率相关。多因素分析显示,PDGFR-β基因表达是生存的独立预测因素。总体而言,该研究表明,胃癌组织中PDGFR-β的过表达是接受S-1辅助化疗的II/III期胃癌患者预后的一个有用的独立预测因素。

相似文献

1
Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy.血小板衍生生长因子受体-β基因表达在II/III期胃癌S-1辅助化疗中的临床意义
Oncol Lett. 2017 Feb;13(2):905-911. doi: 10.3892/ol.2016.5494. Epub 2016 Dec 14.
2
Clinical significance of IGF1R gene expression in patients with Stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1.IGF1R基因表达在接受根治性手术及S-1辅助化疗的II/III期胃癌患者中的临床意义
J Cancer Res Clin Oncol. 2016 Feb;142(2):415-22. doi: 10.1007/s00432-015-2039-6. Epub 2015 Sep 3.
3
Clinical Significance of Gene Expression in Patients with Gastric Cancer who Receive Curative Resection Followed by Adjuvant S-1 Chemotherapy.接受根治性切除术后辅助S-1化疗的胃癌患者基因表达的临床意义
In Vivo. 2017 Jul-Aug;31(4):565-571. doi: 10.21873/invivo.11095.
4
Clinical significance of secreted protein, acidic and cysteine-rich gene expression in patients with stage II/III gastric cancer following curative resection and adjuvant chemotherapy with S-1.根治性切除及S-1辅助化疗后II/III期胃癌患者中富含酸性和半胱氨酸的分泌蛋白基因表达的临床意义
Oncol Lett. 2018 May;15(5):7335-7343. doi: 10.3892/ol.2018.8248. Epub 2018 Mar 13.
5
Clinical Significance of Tensin 4 Gene Expression in Patients with Gastric Cancer.张力蛋白4基因表达在胃癌患者中的临床意义
In Vivo. 2017 Nov-Dec;31(6):1065-1071. doi: 10.21873/invivo.11171.
6
High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1.高γ-谷氨酰水解酶和低叶酸多谷氨酸合成酶表达作为接受 S-1 术后辅助化疗的局部晚期胃癌患者的预后生物标志物。
J Cancer Res Clin Oncol. 2020 Jan;146(1):75-86. doi: 10.1007/s00432-019-03087-8. Epub 2019 Nov 21.
7
Clinicopathological significance of platelet-derived growth factor B, platelet-derived growth factor receptor-β, and E-cadherin expression in gastric carcinoma.血小板衍生生长因子B、血小板衍生生长因子受体-β及E-钙黏蛋白在胃癌中的表达及其临床病理意义
Contemp Oncol (Pozn). 2013;17(2):150-5. doi: 10.5114/wo.2013.34618. Epub 2013 Apr 29.
8
Prognostic relevance of FGFR2 expression in stage II/III gastric cancer with curative resection and S-1 chemotherapy.FGFR2表达在接受根治性切除及S-1化疗的II/III期胃癌中的预后相关性
Oncol Lett. 2018 Feb;15(2):1853-1860. doi: 10.3892/ol.2017.7515. Epub 2017 Dec 5.
9
The clinical significance of platelet-derived growth factors (PDGFs) and their receptors (PDGFRs) in gastric cancer: A systematic review and meta-analysis.血小板衍生生长因子(PDGFs)及其受体(PDGFRs)在胃癌中的临床意义:系统评价和荟萃分析。
Crit Rev Oncol Hematol. 2018 Jul;127:15-28. doi: 10.1016/j.critrevonc.2018.05.004. Epub 2018 May 16.
10
Impact of insulin-like growth factor-1 receptor and amphiregulin expression on survival in patients with stage II/III gastric cancer enrolled in the Adjuvant Chemotherapy Trial of S-1 for Gastric Cancer.胰岛素样生长因子-1受体和双调蛋白表达对入组胃癌S-1辅助化疗试验的II/III期胃癌患者生存的影响。
Gastric Cancer. 2017 Mar;20(2):263-273. doi: 10.1007/s10120-016-0600-x. Epub 2016 Feb 16.

引用本文的文献

1
An integrated analysis of prognostic mRNA signature in early- and progressive-stage gastric adenocarcinoma.早期和进展期胃腺癌预后mRNA特征的综合分析
Front Mol Biosci. 2023 Jan 4;9:1022056. doi: 10.3389/fmolb.2022.1022056. eCollection 2022.
2
Identification of a Biomarker Combination for Survival Stratification in pStage II/III Gastric Cancer after Curative Resection.根治性切除术后Ⅱ/Ⅲ期胃癌生存分层生物标志物组合的鉴定
Cancers (Basel). 2022 Sep 12;14(18):4427. doi: 10.3390/cancers14184427.
3
Nintedanib Induces the Autophagy-Dependent Death of Gastric Cancer Cells by Inhibiting the STAT3/Beclin1 Pathway.尼达尼布通过抑制STAT3/Beclin1通路诱导胃癌细胞自噬依赖性死亡。
Dig Dis Sci. 2023 Apr;68(4):1280-1291. doi: 10.1007/s10620-022-07653-y. Epub 2022 Aug 24.
4
Issues of origin, morphology and clinical significance of tumor microvessels in gastric cancer.胃癌肿瘤微血管的起源、形态及其临床意义。
World J Gastroenterol. 2021 Dec 28;27(48):8262-8282. doi: 10.3748/wjg.v27.i48.8262.
5
Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma.仑卡奈布联合雷莫芦单抗和紫杉醇二线治疗晚期胃食管腺癌的 I/ Ib 期研究。
Cancer Chemother Pharmacol. 2022 Feb;89(2):255-265. doi: 10.1007/s00280-021-04384-1. Epub 2022 Jan 23.
6
Establishment of a Prognostic Signature of Stromal/Immune-Related Genes for Gastric Adenocarcinoma Based on ESTIMATE Algorithm.基于ESTIMATE算法建立胃腺癌基质/免疫相关基因的预后特征
Front Cell Dev Biol. 2021 Nov 24;9:752023. doi: 10.3389/fcell.2021.752023. eCollection 2021.
7
Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer models.多韦替尼靶向抑制 FGFR/VEGFR/PDGFR 增强nab-紫杉醇在胃癌模型中的疗效。
Cancer Biol Ther. 2021 Dec 2;22(10-12):619-629. doi: 10.1080/15384047.2021.2011642. Epub 2021 Dec 9.
8
LOX inhibition downregulates MMP-2 and MMP-9 in gastric cancer tissues and cells.赖氨酰氧化酶抑制可下调胃癌组织和细胞中的基质金属蛋白酶-2和基质金属蛋白酶-9。
J Cancer. 2019 Oct 20;10(26):6481-6490. doi: 10.7150/jca.33223. eCollection 2019.

本文引用的文献

1
Clinicopathological significance of platelet-derived growth factor B, platelet-derived growth factor receptor-β, and E-cadherin expression in gastric carcinoma.血小板衍生生长因子B、血小板衍生生长因子受体-β及E-钙黏蛋白在胃癌中的表达及其临床病理意义
Contemp Oncol (Pozn). 2013;17(2):150-5. doi: 10.5114/wo.2013.34618. Epub 2013 Apr 29.
2
Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer.一项比较辅助化疗 S-1 与单纯手术治疗 II 期或 III 期胃癌的随机 III 期临床试验的 5 年结果。
J Clin Oncol. 2011 Nov 20;29(33):4387-93. doi: 10.1200/JCO.2011.36.5908. Epub 2011 Oct 17.
3
Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma.PDGFR-α、PDGFR-β 和 VEGF 的共表达作为肝癌患者的预后因素。
Int J Biol Markers. 2011 Apr-Jun;26(2):108-16. doi: 10.5301/JBM.2011.8322.
4
Anti-stromal therapy with imatinib inhibits growth and metastasis of gastric carcinoma in an orthotopic nude mouse model.伊马替尼的抗基质治疗抑制原位裸鼠模型中胃癌的生长和转移。
Int J Cancer. 2011 May 1;128(9):2050-62. doi: 10.1002/ijc.25812.
5
Quantitative analysis of vessels with smooth muscle layer in astrocytic tumors: correlation with histological grade and prognostic significance.星形细胞肿瘤中平滑肌层血管的定量分析:与组织学分级的相关性及其预后意义。
Histol Histopathol. 2011 Apr;26(4):497-504. doi: 10.14670/HH-26.497.
6
Global cancer statistics.全球癌症统计数据。
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90. doi: 10.3322/caac.20107. Epub 2011 Feb 4.
7
Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancer.血小板衍生生长因子 (PDGF)-B 和血管内皮生长因子-A 表达、PDGF 受体-β 磷酸化及微血管密度在胃癌中的临床病理意义。
BMC Cancer. 2010 Nov 30;10:659. doi: 10.1186/1471-2407-10-659.
8
Expression of platelet-derived growth factor (PDGF)-B and PDGF-receptor β is associated with lymphatic metastasis in human gastric carcinoma.血小板衍生生长因子 (PDGF)-B 和 PDGF 受体 β 的表达与人类胃癌的淋巴转移相关。
Cancer Sci. 2010 Sep;101(9):1984-9. doi: 10.1111/j.1349-7006.2010.01639.x.
9
Effect of pazopanib on tumor microenvironment and liposome delivery.帕唑帕尼对肿瘤微环境和脂质体传递的影响。
Mol Cancer Ther. 2010 Jun;9(6):1798-808. doi: 10.1158/1535-7163.MCT-09-0856. Epub 2010 Jun 1.
10
Stromal PDGFRbeta expression in prostate tumors and non-malignant prostate tissue predicts prostate cancer survival.前列腺肿瘤和非恶性前列腺组织中的基质 PDGFRβ表达可预测前列腺癌的生存。
PLoS One. 2010 May 20;5(5):e10747. doi: 10.1371/journal.pone.0010747.